We are live on ! Find out more
N

NanoDimension Portfolio holdings

AUM $24.7M
1-Year Est. Return 74.01%
This Fund
S&P 500
This Quarter Est. Return
-25.41%
1 Year Est. Return
-74.01%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$112M
AUM Growth
Cap. Flow
+$133M
Cap. Flow %
119.61%
Top 10 Hldgs %
100%
Holding
4
New
4
Increased
Reduced
Closed

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ICVX
1
DELISTED
Icosavax, Inc. Common Stock
ICVX
$62.9M 56.41%
+2,749,994
New +$71M
TWST icon
2
Twist Bioscience
TWST
$5.8B
$23.8M 21.35%
+307,740
New +$31.6M
SQZ
3
DELISTED
SQZ Biotechnologies Company
SQZ
$12.9M 11.57%
+1,445,221
New +$17.7M
RNAC icon
4
Cartesian Therapeutics
RNAC
$235M
$11.9M 10.66%
+121,597
New +$13.1M

Similar funds

NanoDimension's Q4 2021 Portfolio in Review

Q4 2021 is the first quarter with a 13F filing on record for NanoDimension, which disclosed 4 positions worth $112M. Its ten largest holdings account for 100% of the portfolio.

Its largest position is Icosavax, Inc. Common Stock: 2,749,994 shares worth $62.9M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets.

  • NanoDimension's largest Q4 2021 buy was Icosavax, Inc. Common Stock: 2,749,994 shares worth $62.9M.
  • NanoDimension's ten largest holdings make up 100% of its $112M portfolio in Q4 2021.
  • NanoDimension disclosed 4 positions in Q4 2021, its first 13F filing on record.

Based on NanoDimension's 13F filing for Q4 2021, filed 23 Feb 2022.